The DOI matches its Crossref record.
Problems of Heart Rate Correction in Assessment of Drug‐Induced QT Interval Prolongation
Abstract
Problems of Drug‐Prolonged QTc Assessment. Introduction: Estimation of QT interval prolongation belongs to safety assessment of every drug. Among unresolved issues, heart rate correction of the QT interval may be problematic. This article proposes a strategy for heart rate correction in drug safety studies and demonstrates the strategy using a study of ebastine, a nonsedating antihistamine. Methods and Results: Four‐way cross‐over Phase I study investigated 32 subjects on placebo, ebastine 60 mg once a day, 100 mg once a day, and terfenadine 180 mg twice a day. Repeated ECGs were obtained before each arm and after 7 days of treatment. The changes in heart rate‐corrected QTc interval were investigated using (A) 20 published heart rate correction formulas, (B) a correction formula optimized by QT/RR regression modeling in all baseline data, and (C) individual corrections optimized for each subject by drug‐free QT/RR regression modeling. (A) Previously published correction formulas found QTc interval increases on terfenadine. The results with ebastine were inconsistent. For instance, Bazett's and Lecocq's correction found significant QTc increase and decrease on ebastine, respectively. The results were related (|r| > 0.95) to the success of each formula (independence of drug‐free QTc and RR intervals). (B) The pooled drug‐free QT/RR regression found an optimized correction QTc = QT/RR 0.314. QTc interval changes on placebo, ebastine 60 mg, ebastine 100 mg, and terfenadine were − 1.95 ± 6.87 msec (P = 0.18), − 3.91 ± 9.38 msec (P = 0.053), 0.75 ± 8.23 msec (P = 0.66), and 12.95 ± 14.64 msec (P = 0.00025), respectively. (C) Individual QT/RR regressions were significantly different between subjects and found optimized corrections QTc = QT/RR α with α= 0.161 to 0.417. Individualized QTc interval changes on placebo, ebastine 60 mg, ebastine 100 mg, and terfenadine were − 2.76 ± 5.51 msec (P = 0.022), − 3.15 ± 9.17 msec (P = 0.11), − 2.61 ± 9.55 msec (P = 0.19), and 12.43 ± 15.25 msec (P = 0.00057), respectively. Drug‐unrelated QTc changes up to 4.70 ± 8.92 msec reflected measurement variability. Conclusion: Use of published heart rate correction formulas in the assessment of drug‐induced QTc prolongation is inappropriate, especially when the drug might induce heart rate changes. Correction formulas optimized for pooled drug‐free data are inferior to the formulas individualized for each subject. Measurement imprecision and natural variability can lead to mean QTc interval changes of 4 to 5 msec in the absence of drug treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
What Clinicians Should Know About the QT Interval
Al-Khatib, S. M., LaPointe, N. M. A., Kramer, J. M., & Califf, R. M. (2003) · JAMA · doi:10.1001/jama.289.16.2120 · Cited by 667
Malik, M., Färbom, P., Batchvarov, V, Hnatkova, K., & Camm, A. J. (2002) · Heart · doi:10.1136/heart.87.3.220 · Cited by 436
Self-citationWhich QT Correction Formulae to Use for QT Monitoring?
Vandenberk, B., Vandael, E., Robyns, T., Vandenberghe, J., Garweg, C., Foulon, V., Ector, J., & Willems, R. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003264 · Cited by 404
Maron, B. J., Friedman, R. A., Kligfield, P., Levine, B. D., Viskin, S., Chaitman, B. R., Okin, P. M., Saul, J. P., Salberg, L., Van Hare, G. F., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000025 · Cited by 390
Drug‐Induced Torsades de Pointes and Implications for Drug Development
FENICHEL, R. R., MALIK, M., ANTZELEVITCH, C., SANGUINETTI, M., RODEN, D. M., PRIORI, S. G., RUSKIN, J. N., LIPICKY, R. J., CANTILENA, L. R., & Independent Academic Task Force (2004) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2004.03534.x · Cited by 346
Self-citation
Metadata
- Authors
- MALIK, M.
- Venue
- Journal of Cardiovascular Electrophysiology
- Publisher
- Wiley
- Published
- 2001-04
- Volume
- 12
- Issue
- 4
- Pages
- 411-420
- ISSN
- 1045-3873 (ISSN-L)
- 1540-8167
- OpenAlex
- W2159163894
- Cited by
- 276
- References
- 0
- FWCI
- 10.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Problems of Heart Rate Correction in Assessment of Drug‐Induced QT Interval Prolongation. https://app.cochat.ai/papers/10.1046/j.1540-8167.2001.00411.x
- The paper
- MALIK, M. (2001). Problems of Heart Rate Correction in Assessment of Drug‐Induced QT Interval Prolongation. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1046/j.1540-8167.2001.00411.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.